(19)
(11) EP 2 059 206 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
11.07.2012 Bulletin 2012/28

(45) Mention of the grant of the patent:
16.05.2012 Bulletin 2012/20

(21) Application number: 07841486.9

(22) Date of filing: 28.08.2007
(51) International Patent Classification (IPC): 
A61F 13/00(2006.01)
A61K 9/19(2006.01)
A61L 15/12(2006.01)
(86) International application number:
PCT/US2007/077014
(87) International publication number:
WO 2008/027904 (06.03.2008 Gazette 2008/10)

(54)

DRY WOUND DRESSING AND DRUG DELIVERY SYSTEM

TROCKENER WUNDVERBAND UND WIRKSTOFFVERABREICHUNGSSYSTEM

PANSEMENT DE PLAIE SEC ET SYSTÈME DE DÉLIVRANCE DE MÉDICAMENT


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 28.08.2006 US 840265 P

(43) Date of publication of application:
20.05.2009 Bulletin 2009/21

(60) Divisional application:
12167927.8

(73) Proprietor: Rexaderm, Inc.
Fort Lauderdale, FL 33308-6939 (US)

(72) Inventor:
  • GOODHEART, Clyde Raymond
    Fort Lauderdale, Florida 33308-6939 (US)

(74) Representative: Grund, Martin et al
Grund Intellectual Property Group Nikolaistrasse 15
80802 München
80802 München (DE)


(56) References cited: : 
EP-A1- 0 526 865
US-A- 5 124 155
US-A1- 2004 254 143
US-B2- 6 828 308
WO-A2-02/09637
US-A1- 2004 029 843
US-B1- 6 548 380
   
  • HITA-IGLESIAS ET AL: "Evaluation of the clinical behaviour of a polyvinylpyrrolidone and sodium hyalonurate gel (Gelclair<(>R)) in patients subjected to surgical treatment with CO2 laser" INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, COPENHAGEN, DK, vol. 35, no. 6, 1 June 2006 (2006-06-01), pages 514-517, XP005437546 ISSN: 0901-5027
  • WRIGHT J ET AL: "CHEMOTHERAPY-INDUCED ORAL MUCOSITIS: NEW APPROACHES TO PREVENTION AND MANAGEMENT" EXPERT OPINION ON DRUG SAFETY, ASHLEY, LONDON, GB LNKD- DOI:10.1517/14740338.4.2.193, vol. 4, no. 2, 1 January 2005 (2005-01-01) , pages 193-200, XP009055602 ISSN: 1474-0338
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).